Latest FluMist Stories
MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved
-- The Novartis influenza vaccine portfolio in the US includes Flucelvax® and Fluvirin® CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment
New analysis of the 2009 H1N1 influenza pandemic in the US shows that the pandemic wave was surprisingly slow, and that its spread was likely accelerated by school-age children.
- Triggered by ongoing and very successful multi-year collaboration TUBINGEN, Germany, July 1, 2014 /PRNewswire/ -- CureVac, a German clinical-stage biopharmaceutical company, today
BEIJING, June 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd.
TITUSVILLE, New Jersey, June 18, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc.
MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the
First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc.
Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic BASEL, Switzerland, June 16, 2014
MERIDEN, Conn., June 10, 2014 /PRNewswire/ -- Protein Sciences Corporation announced it will have more doses, earlier
- Withering but not falling off, as a blossom that persists on a twig after flowering.